Posizolid: Difference between revisions

Posizolid
Clinical data
Other names	AZD2563
ATC code	none;
Identifiers
	IUPAC name (5R)-3-[4-[1-[(2S)-2,3-Dihydroxypropanoyl]-3,6-dihydro-2H-pyridin-4-yl]-3,5-difluorophenyl]-5-(1,2-oxazol-3-yloxymethyl)-1,3-oxazolidin-2-one;
CAS Number	252260-02-9;
PubChem CID	213049;
CompTox Dashboard (EPA)	DTXSID40870284 DTXSID00948079, DTXSID40870284 ;
ECHA InfoCard	100.234.485
Chemical and physical data
Formula	C21H21F2N3O7
Molar mass	465.40 g/mol g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C1N(CC3=CC(F)=C(C4=CCN(C([C@@H](O)CO)=O)CC4)C(F)=C3)C[C@H](OC2=NOC=C2)O1;

Content deleted Content added

Inline

Revision as of 03:30, 6 September 2009

Posizolid is an oxazolidinone antibiotic under investigation for the treatment of bacterial infections.^[1]

^ Wookey, A.; Turner, P. J.; Greenhalgh, J. M.; Eastwood, M.; Clarke, J.; Sefton, C. (2004). "AZD2563, a novel oxazolidinone: definition of antibacterial spectrum, assessment of bactericidal potential and the impact of miscellaneous factors on activity in vitro". Clinical Microbiology and Infection. 10 (3): 247–254.{{cite journal}}: CS1 maint: multiple names: authors list (link)

This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it.

@@ Line 34: / Line 34: @@
 {{antibiotic-stub}}
+{{Protein synthesis inhibitor antibiotics}}
 [[Category:Oxazolidinone antibiotics]]